WO2011118625A1 - 光学活性なn-モノアルキル-3-ヒドロキシ-3-アリールプロピルアミン化合物の製造方法 - Google Patents
光学活性なn-モノアルキル-3-ヒドロキシ-3-アリールプロピルアミン化合物の製造方法 Download PDFInfo
- Publication number
- WO2011118625A1 WO2011118625A1 PCT/JP2011/056971 JP2011056971W WO2011118625A1 WO 2011118625 A1 WO2011118625 A1 WO 2011118625A1 JP 2011056971 W JP2011056971 W JP 2011056971W WO 2011118625 A1 WO2011118625 A1 WO 2011118625A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hydroxy
- monoalkyl
- oxo
- benzyl
- compound
- Prior art date
Links
- 0 *NCCC(O)[Al] Chemical compound *NCCC(O)[Al] 0.000 description 1
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N CCc1ccccc1 Chemical compound CCc1ccccc1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B53/00—Asymmetric syntheses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
Definitions
- the present invention relates to a method for producing an optically active N-monoalkyl-3-hydroxy-3-arylpropylamine compound.
- An N-monoalkyl-3-hydroxy-3-arylpropylamine compound is a useful compound as an intermediate for various pharmaceuticals and the like.
- a method for producing an optically active compound its racemate is converted into an optically active organic compound.
- a method of optical resolution using a resolving agent such as an acid is known (Patent Document 1).
- Patent Document 1 A method of optical resolution using a resolving agent such as an acid is known (Patent Document 1).
- Patent Document 1 A method of optical resolution using a resolving agent such as an acid is known (Patent Document 1).
- Patent Document 1 is an optical resolution method, only about half of the racemate can be used, which is disadvantageous in terms of yield, and there are various problems such as the need to recycle the resolution agent.
- Patent Document 2 Also known is a method of dealkylating an N, N-dialkyl-3-hydroxy-3-arylpropylamine compound using a dealkylating agent (Patent Document 2).
- Patent Document 2 a method of dealkylating an N, N-dialkyl-3-hydroxy-3-arylpropylamine compound using a dealkylating agent.
- this method is disadvantageous economically because a dealkylating agent is required to be twice or more moles relative to the substrate.
- the present invention has been made in view of the above-mentioned problems of the prior art, and its main object is to provide an optically active N-monoalkyl-3-hydroxy-3-arylpropylamine compound that is industrially advantageous. It is to provide a method that can be manufactured easily and inexpensively under conditions.
- the present inventor has intensively studied to achieve the above-mentioned purpose.
- an N-benzyl-N-monoalkyl-3-oxo-3-arylpropenylamine compound as a raw material and reacting with hydrogen in the presence of an asymmetric reduction catalyst, an asymmetric reduction reaction and debenzylation are performed.
- the target optically active N-monoalkyl-3-hydroxy-3-arylpropylamine compound can be produced in good yield and at low yield by an industrially advantageous method.
- the present invention has been completed.
- the present invention provides the following method for producing an optically active N-monoalkyl-3-hydroxy-3-arylpropylamine compound. 1.
- an asymmetric reduction catalyst In the presence of an asymmetric reduction catalyst, general formula (1):
- Ar represents an aryl group which may have a substituent or a heteroaryl group which may have a substituent
- R represents an optionally substituted substituent having 1 to 5 carbon atoms.
- Ar represents an optionally substituted aryl group or an optionally substituted heteroaryl group
- R represents an optionally substituted carbon atom having 1 to 5 carbon atoms.
- the substitution position for the carbon-carbon double bond may be either cis or trans.
- the compound is a known compound and can be obtained, for example, by reacting an aqueous N-alkyl-N-benzylamine hydrochloride solution with an alkali metal salt of ⁇ -oxo- ⁇ - (aryl or heteroaryl) propanal. it can.
- examples of the aryl group represented by Ar include a phenyl group, a naphthyl group, and a phenanthryl group.
- examples of the heteroaryl group include a furyl group, a thienyl group, a pyrrolyl group, a pyridyl group, a benzofuryl group, and an indenyl group.
- Examples of the alkyl group having 1 to 5 carbon atoms represented by R include a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a tert-butyl group, and an n-pentyl group. Examples thereof include a linear or branched alkyl group having 1 to 5 carbon atoms.
- any of the above-mentioned aryl group, heteroaryl group and alkyl group may contain one or two or more substituents, and when two or more substituents are contained, they may contain the same or different substituents.
- substituents include hydroxyl group, methyl group, ethyl group, propyl group, trifluoromethyl group, methoxy group, nitro group, amino group, methylsulfonylamino group, benzoyloxy group, fluorine atom, chlorine atom, bromine atom. And iodine atom.
- N-benzyl-N-monoalkyl-3-oxo-3-arylpropenylamine compound represented by the general formula (1) include N-methyl-N-benzyl-3-oxo-3-phenyl.
- Ar represents an aryl group which may have a substituent or a heteroaryl group which may have a substituent
- R represents an optionally substituted carbon atom having 1 to 5 carbon atoms.
- an asymmetric reduction reaction and a debenzylation reaction proceed by a simple method of reacting a raw material compound with hydrogen gas, and an optically active N-monoalkyl represented by the general formula (2)
- a -3-hydroxy-3-arylpropylamine compound can be obtained with high purity and low cost. Therefore, the method of the present invention is an industrially very advantageous method for producing an optically active N-monoalkyl-3-hydroxy-3-arylpropylamine compound.
- the asymmetric reduction catalyst is not particularly limited, and various transition metal complexes can be used.
- Specific examples of such an asymmetric reduction catalyst include RuCl 2 [(S) -BINAP] [(S, S) -DPEN], RuCl 2 [(S) -BINAP] [(S) -DAIPEN], RuCl 2 [(S) -BINAP] [(R, R) -DPEN], RuCl 2 [(R) -BINAP] [(S, S) -DPEN], RuCl 2 [(R) -BINAP] [(R, R) -DPEN], RuCl 2 [(R) -BINAP] [(R, R) -DPEN], RuCl 2 [(R) -BINAP] [(R) -DAIPEN], RuCl 2 [(S) -Tol-BINAP] [(S, S) -DPEN], RuCl 2 [(S) -Tol-BINAP] [
- BINAP represents 2,2′-bis- (diphenylphosphino) -1,1′-binaphthyl
- Tol-BINAP represents 2,2′-bis- (ditolylphenylphosphino) -1,1.
- DPEN represents 1,2-diphenyl-ethylenediamine
- DAIPEN represents 1,1-di (4-anisyl) -2-isopropyl-1,2-ethylenediamine.
- the amount of the asymmetric reduction catalyst used is 0.0001 to 0.1 mol relative to 1 mol of the N-benzyl-N-monoalkyl-3-oxo-3-arylpropenylamine compound represented by the general formula (1).
- the amount is preferably about 0.0005 to 0.02 mol.
- the reaction of the N-benzyl-N-monoalkyl-3-oxo-3-arylpropenylamine compound represented by the general formula (1) with hydrogen is usually N-benzyl-N-monoalkyl-3-oxo. It can be carried out by blowing hydrogen gas into a solution in which a -3-arylpropenylamine compound and an asymmetric carbon catalyst are dissolved or dispersed, or by filling hydrogen gas into a reaction vessel containing the solution.
- the pressure of hydrogen gas is preferably about 0.001 to 150 MPa, more preferably about 0.1 to 100 MPa.
- reaction solvent examples include alcohols such as methanol, ethanol and 2-propanol; halogenated hydrocarbons such as methylene chloride and 1,2-dichloroethane; ethers such as diethyl ether and tert-butyl methyl ether can be used. .
- the amount of the reaction solvent used is about 1 to 1000 parts by weight with respect to 1 part by weight of the N-benzyl-N-monoalkyl-3-oxo-3-arylpropenylamine compound represented by the general formula (1). Is preferably about 5 to 100 parts by weight.
- the reaction temperature is preferably about ⁇ 20 to 150 ° C., more preferably about 0 to 100 ° C.
- the reaction time is usually about 1 to 24 hours.
- Bases include metal hydroxides such as lithium hydroxide, sodium hydroxide, potassium hydroxide, calcium hydroxide; metal alkoxides such as sodium methoxide, potassium ethoxide, tert-butoxy sodium, tert-butoxy potassium; hydrogenation Examples thereof include metal hydrides such as potassium and sodium hydride.
- the use ratio of the base is preferably about 0.1 to 10 mol, more preferably about 0.5 to 4 mol, relative to 1 mol of the asymmetric reduction catalyst.
- reaction solution for example, after concentration, a water-insoluble reaction solvent such as toluene or diethyl ether and water are added to the remaining residue, and then an alkali is added to separate the aqueous layer as basic to obtain an organic layer. Thereafter, the target N-monoalkyl-3-hydroxy-3-arylpropylamine compound can be isolated by concentrating the obtained organic layer. Further, the obtained N-monoalkyl-3-hydroxy-3-arylpropylamine compound can be purified by a method such as silica gel column chromatography or distillation.
- a water-insoluble reaction solvent such as toluene or diethyl ether and water are added to the remaining residue, and then an alkali is added to separate the aqueous layer as basic to obtain an organic layer.
- the target N-monoalkyl-3-hydroxy-3-arylpropylamine compound can be isolated by concentrating the obtained organic layer. Further, the obtained N-monoalkyl-3-hydroxy-3-arylpropy
- N-monoalkyl-3-hydroxy-3-arylpropylamine compound is obtained.
- N-monoalkyl-3-hydroxy-3-arylpropylamine compound include N-methyl-3-hydroxy-3-phenylpropylamine, N-ethyl-3-hydroxy-3- (4-toluyl) Propylamine, N-ethyl-3-hydroxy-3- (4-trifluoromethylphenyl) propylamine, N-methyl-3-hydroxy-3- (4-methoxyphenyl) propylamine, N- (n-propyl) -3-hydroxy-3- (4-nitrophenyl) propylamine, N- (tert-butyl) -3-hydroxy-3- (3-methylsulfonylaminophenyl) propylamine, N-methyl-3-hydroxy-3 -(4-Benzoyloxyphenyl) propylamine,
- an optically active N-monoalkyl-3-hydroxy-3-arylpropylamine compound that is useful as an intermediate for various medicines and the like can be obtained with high purity and low cost by a simple production process. Can get to. Therefore, the method of the present invention is an industrially very advantageous method for producing an N-monoalkyl-3-hydroxy-3-arylpropylamine compound having optical activity.
- Production Example 1 A 4-liter flask having a volume of 1 L equipped with a stirrer, a condenser, a thermometer and a dropping funnel was charged with 88.1 g (0.50 mol) of sodium salt of ⁇ -oxo- ⁇ - (2-thienyl) propanal and 168 g of methanol. N-methyl-N-benzylamine hydrochloride aqueous solution (0.50 mol) was added dropwise at 10 ° C. over 30 minutes and reacted at 30 ° C. for 5 hours.
- Production Example 2 Production Example 1 except that an N-ethyl-N-benzylamine hydrochloride aqueous solution (0.50 mol) was used in place of the N-methyl-N-benzylamine hydrochloride aqueous solution (0.50 mol).
- 111.3 g (0.410 mol) of N-ethyl-N-benzyl-3-oxo-3- (2-thienyl) propenamine was obtained.
- the yield based on the sodium salt of ⁇ -oxo- ⁇ - (2-thienyl) propanal was 82%.
- Example 1 In a two-necked flask with a volume of 20 ml, under an argon atmosphere, 128.7 mg (0.50 mmol) of N-methyl-N-benzyl-3-oxo-3- (2-thienyl) propenylamine obtained in Preparation Example 1 was obtained. , RuCl 2 [(R) -BINAP] [(R) -DAIPEN] complex 5.5 mg (0.0050 mmol) and 2-propanol 2-ml, and a 2-propanol solution of tert-butoxypotassium at a concentration of 0.5 mol / L 20 ⁇ l was added. Next, hydrogen was charged at a pressure of 1 MPa and reacted at 80 ° C. for 16 hours.
- Example 2 Instead of N-methyl-N-benzyl-3-oxo-3- (2-thienyl) propenylamine 128.7 mg (0.50 mmol) in Example 1, N-ethyl-N (S) -N-ethyl-3-hydroxy-Similar to Example 1 except that 135.7 mg (0.50 mmol) of -benzyl-3-oxo-3- (2-thienyl) propenylamine was used. 76.0 mg (0.41 mmol) of 3- (2-thienyl) propylamine was obtained. The yield based on N-ethyl-N-benzyl-3-oxo-3- (2-thienyl) propenylamine was 82%.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Abstract
Description
1. 不斉還元触媒の存在下で、一般式(1):
で表されるN-モノアルキル-3-ヒドロキシ-3-アリールプロピルアミン化合物の製造方法。
2. 不斉還元触媒が遷移金属錯体である上記項1に記載の製造方法。
3. 更に、塩基の存在下に反応を行う上記項1又は2に記載の製造方法。
本発明の製造方法では、原料として、下記一般式(1):
本発明の目的物である一般式(2):
このために、本発明方法は、光学活性を有するN-モノアルキル-3-ヒドロキシ-3-アリールプロピルアミン化合物の製造方法として工業的に非常に有利な方法である。
攪拌機、冷却管、温度計および滴下ロートを備え付けた容積1Lの4つ口フラスコに、β-オキソ-β-(2-チエニル)プロパナールのナトリウム塩88.1g(0.50モル)、メタノール168gを仕込み、N-メチル-N-ベンジルアミン塩酸塩水溶液(0.50モル)を10℃で30分を要して滴下し、滴下終了後30℃で5時間反応させた。
製造例1において、N-メチル-N-ベンジルアミン塩酸塩水溶液(0.50モル)に代えて、N-エチル-N-ベンジルアミン塩酸塩水溶液(0.50モル)を用いた以外は、製造例1と同様にして、N-エチル-N-ベンジル-3-オキソ-3-(2-チエニル)プロペンアミン111.3g(0.410モル)を得た。β-オキソ-β-(2-チエニル)プロパナールのナトリウム塩に対する収率は、82%であった。
容積20mlの二つ口フラスコに、アルゴン雰囲気下で、製造例1において得られたN-メチル-N-ベンジル-3-オキソ-3-(2-チエニル)プロペニルアミン128.7mg(0.50mmol)、RuCl2[(R)-BINAP][(R)-DAIPEN]錯体5.5mg(0.0050mmol)および2-プロパノール2mlを仕込み、濃度0.5mol/Lのtert-ブトキシカリウムの2-プロパノール溶液20μlを添加した。次いで、水素を1MPaの圧力で充填し、80℃にて16時間反応させた。
実施例1において、N-メチル-N-ベンジル-3-オキソ-3-(2-チエニル)プロペニルアミン128.7mg(0.50mmol)に代えて、製造例2において得られたN-エチル-N-ベンジル-3-オキソ-3-(2-チエニル)プロペニルアミン135.7mg(0.50mmol)を用いた以外は、実施例1と同様にして、(S)-N-エチル-3-ヒドロキシ-3-(2-チエニル)プロピルアミン76.0mg(0.41mmol)を得た。N-エチル-N-ベンジル-3-オキソ-3-(2-チエニル)プロペニルアミンに対する収率は、82%であった。
Claims (3)
- 不斉還元触媒が遷移金属錯体である請求項1に記載の製造方法。
- 更に、塩基の存在下に反応を行う請求項1又は2に記載の製造方法。
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011800157962A CN102822161A (zh) | 2010-03-24 | 2011-03-23 | 制造光学活性n-单烷基-3-羟基-3-芳基丙胺化合物的方法 |
JP2012507030A JPWO2011118625A1 (ja) | 2010-03-24 | 2011-03-23 | 光学活性なn−モノアルキル−3−ヒドロキシ−3−アリールプロピルアミン化合物の製造方法 |
US13/583,376 US8981122B2 (en) | 2010-03-24 | 2011-03-23 | Method for producing optically active N-monoalkyl-3-hydroxy-3-arylpropylamine compound |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010-067904 | 2010-03-24 | ||
JP2010067904 | 2010-03-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2011118625A1 true WO2011118625A1 (ja) | 2011-09-29 |
Family
ID=44673176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2011/056971 WO2011118625A1 (ja) | 2010-03-24 | 2011-03-23 | 光学活性なn-モノアルキル-3-ヒドロキシ-3-アリールプロピルアミン化合物の製造方法 |
Country Status (4)
Country | Link |
---|---|
US (1) | US8981122B2 (ja) |
JP (1) | JPWO2011118625A1 (ja) |
CN (1) | CN102822161A (ja) |
WO (1) | WO2011118625A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2987780B1 (en) * | 2013-04-18 | 2019-10-02 | Mitsubishi Gas Chemical Company, Inc. | Polyol-ether compound and method for producing same |
CN103554403B (zh) * | 2013-10-30 | 2015-09-30 | 刘芳 | 一种水性光固化氨基树脂及制备方法 |
US11497223B2 (en) | 2017-06-30 | 2022-11-15 | Nordischer Maschinenbau Rud. Baader Gmbh + Co. Kg | Conveying device and method for conveying poultry bodies, and apparatus and method for recovering fillets from poultry bodies |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04226948A (ja) * | 1990-05-17 | 1992-08-17 | Eli Lilly & Co | 1−アリール−3−アミノプロパン−1−オール類のキラル合成 |
WO2003097632A1 (fr) * | 2002-05-20 | 2003-11-27 | Mitsubishi Rayon Co., Ltd. | Derives de propanolamine, procede de preparation de 3-n-methylamino-1-(2-thienyl)-1-propanols et procede de preparation de derives de propanolamine |
JP2004155770A (ja) * | 2002-10-18 | 2004-06-03 | Toru Yokozawa | 光学活性アミノアルコールの製造方法 |
WO2004103990A1 (ja) * | 2003-05-22 | 2004-12-02 | Sumitomo Seika Chemicals Co. Ltd. | 光学活性n-モノアルキル-3-ヒドロキシ-3-アリールプロピルアミン類の製造方法および中間体 |
JP2005536556A (ja) * | 2002-08-27 | 2005-12-02 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | アミノアルコールのエナンチオ選択的水素化法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL99316A (en) | 1991-08-27 | 1995-03-15 | Teva Pharma | Production of fluoxetine and new intermediates |
JP4483165B2 (ja) | 2002-10-01 | 2010-06-16 | 山川薬品工業株式会社 | 光学活性な3−(メチルアミノ)−1−(2−チエニル)プロパン−1−オールの製造方法および製造の中間体 |
ATE384038T1 (de) | 2002-10-18 | 2008-02-15 | Tohru Yokozawa | Verfahren zur herstellung optisch aktiver aminoalkohole |
-
2011
- 2011-03-23 JP JP2012507030A patent/JPWO2011118625A1/ja active Pending
- 2011-03-23 WO PCT/JP2011/056971 patent/WO2011118625A1/ja active Application Filing
- 2011-03-23 CN CN2011800157962A patent/CN102822161A/zh active Pending
- 2011-03-23 US US13/583,376 patent/US8981122B2/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04226948A (ja) * | 1990-05-17 | 1992-08-17 | Eli Lilly & Co | 1−アリール−3−アミノプロパン−1−オール類のキラル合成 |
WO2003097632A1 (fr) * | 2002-05-20 | 2003-11-27 | Mitsubishi Rayon Co., Ltd. | Derives de propanolamine, procede de preparation de 3-n-methylamino-1-(2-thienyl)-1-propanols et procede de preparation de derives de propanolamine |
JP2005536556A (ja) * | 2002-08-27 | 2005-12-02 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | アミノアルコールのエナンチオ選択的水素化法 |
JP2004155770A (ja) * | 2002-10-18 | 2004-06-03 | Toru Yokozawa | 光学活性アミノアルコールの製造方法 |
WO2004103990A1 (ja) * | 2003-05-22 | 2004-12-02 | Sumitomo Seika Chemicals Co. Ltd. | 光学活性n-モノアルキル-3-ヒドロキシ-3-アリールプロピルアミン類の製造方法および中間体 |
Non-Patent Citations (1)
Title |
---|
SAKURABA S ET AL.: "Practical Asymmetric Synthesis of (R)-Fluoxetine Hydrochloride Catalyzed by (2S,4S)-4-Dicyclohexylphosphino-2-diphenylphosphinomethyl-1-(N-methylcarbamoyl)pyrrolidine-Rhodium Complex", SYNLETT, no. 10, September 1991 (1991-09-01), pages 689 - 690, XP002353757 * |
Also Published As
Publication number | Publication date |
---|---|
CN102822161A (zh) | 2012-12-12 |
US8981122B2 (en) | 2015-03-17 |
US20130005992A1 (en) | 2013-01-03 |
JPWO2011118625A1 (ja) | 2013-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7582776B2 (en) | Process for preparing arylaminopropanols | |
WO2011118625A1 (ja) | 光学活性なn-モノアルキル-3-ヒドロキシ-3-アリールプロピルアミン化合物の製造方法 | |
EP3207018A1 (en) | Process for the preparation of 1-(3,5-dichloro-4-fluoro-phenyl)-2,2,2-trifluoro-ethanone | |
CN102731326A (zh) | 一种合成(s)-2-氨基-5-甲氧基-1,2,3,4-四氢萘盐酸盐的方法 | |
JP6615212B2 (ja) | 1−(2−ハロゲン−エチル)−4−ピぺリジンカルボン酸エチルエステルの製法 | |
JP5112670B2 (ja) | 置換アミノ酸シッフ塩基化合物の製造方法 | |
CN109970560B (zh) | 一种三取代的1,3二烯烃类化合物的制备方法 | |
JPWO2017090746A1 (ja) | ペンタフルオロスルファニルピリジン | |
US20090209780A1 (en) | Process for producing optically active 2-hydroxybutyric ester | |
JP6213999B2 (ja) | アミン化合物、光学活性アミン、光学活性アミンを含む不斉触媒および不斉触媒を用いた光学活性ハロゲン化合物の製造方法 | |
JP2006063049A (ja) | フェニルシクロヘキセン誘導体またはスチレン誘導体の製造方法 | |
JP3677786B2 (ja) | アリールオキシプロピオン酸の製造法 | |
CN102516202B (zh) | N-氟代-1, 1’-联萘-2, 2’-磺酰亚胺及其制备方法 | |
JP4918736B2 (ja) | 新規光学活性ルテニウム錯体、その製法並びにそれを用いた光学活性化合物の製造方法 | |
JP4896476B2 (ja) | メチルオキシメチルアミノピリジン誘導体及びその製造方法 | |
JP6182183B2 (ja) | デュロキセチン塩基及びデュロキセチン塩酸塩の製造方法 | |
JP5189278B2 (ja) | 2−アシルヘテロ芳香族化合物の捕集方法 | |
JPS6366131A (ja) | 含フツ素脂肪族置換芳香族化合物の製法 | |
KR101465351B1 (ko) | 비대칭 알돌촉매 반응을 통한 키랄성 베타-하이드록시 싸이오에스터 화합물의 제조방법 및 이에 의해 제조된 키랄성 베타-하이드록시 싸이오에스터 화합물 | |
JP2005306804A (ja) | 光学活性3−キヌクリジノールの製造方法 | |
CN104030997B (zh) | 一种用于埃索美拉唑不对称合成的催化剂 | |
JP4475901B2 (ja) | 3−アセチルチオフェン類の製造方法 | |
KR101478597B1 (ko) | 질소 치환 아미노-5,6,7,8-테트라하이드로나프톨의 공업화 제조방법 | |
JP5189279B2 (ja) | 2−アシルヘテロ芳香族化合物の製造方法 | |
US8957227B2 (en) | Preparation of Duloxetine® hydrochloride using optically active methylhydroxylaminopropanol compound as an intermediate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201180015796.2 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11759430 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 7721/DELNP/2012 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012507030 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13583376 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11759430 Country of ref document: EP Kind code of ref document: A1 |